Showing results (11-20 of 64) with videos related to
Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|August 7, 2010
N(G)-Acyl-argininamides as NPY Y(1) receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinityStefan Weiss, Max Keller, Günther Bernhardt, et al.Bioorganic & Medicinal Chemistry|October 1, 2013
Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptorsMax Keller, Melanie Kaske, Tobias Holzammer, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|October 31, 2024
Differential uptake of arginine derivatives by the human heteromeric amino acid transporter b0,+AT-rBAT (SLC7A9-SLC3A1)Sofna Banjarnahor, Lorenz A Scherpinski, Max Keller, et al.Journal of the American Chemical Society|August 12, 2010
Conformations, conformational preferences, and conformational exchange of N'-substituted N-acylguanidines: intermolecular interactions hold the keyRoland Kleinmaier, Max Keller, Patrick Igel, et al.Journal of Medicinal Chemistry|September 29, 2023
[3H]UR-JG102-A Radiolabeled Cyclic Peptide with High Affinity and Excellent Selectivity for the Neuropeptide Y Y4 ReceptorJakob Gleixner, Albert O Gattor, Laura J Humphrys, et al.Scientific Reports|September 12, 2019
18F-labelled triazolyl-linked argininamides targeting the neuropeptide Y Y1R for PET imaging of mammary carcinomaSimone Maschauer, Julian J Ott, Günther Bernhardt, et al.RSC Medicinal Chemistry|January 22, 2021
Differently fluorescence-labelled dibenzodiazepinone-type muscarinic acetylcholine receptor ligands with high M2R affinityCorinna G Gruber, Andrea Pegoli, Christoph Müller, et al.ACS Medicinal Chemistry Letters|March 19, 2020
An Alkyne-functionalized Arginine for Solid-Phase Synthesis Enabling "Bioorthogonal" Peptide ConjugationKatrin Spinnler, Lara von Krüchten, Adam Konieczny, et al.Bioorganic & Medicinal Chemistry|February 3, 2015
Dimeric carbamoylguanidine-type histamine H2 receptor ligands: A new class of potent and selective agonistsNicole Kagermeier, Kristin Werner, Max Keller, et al.Journal of Medicinal Chemistry|December 5, 2008
Guanidine-acylguanidine bioisosteric approach in the design of radioligands: synthesis of a tritium-labeled N(G)-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide Y Y1 receptor antagonistMax Keller, Nathalie Pop, Christoph Hutzler, et al.Pageof 7